33018-91-6 Usage
Description
BOC-HIS(TOS)-MERRIFIELD RESIN is a type of resin used in peptide synthesis, specifically in the Merrifield method. It is a solid support for the stepwise addition of amino acids to form peptides, allowing for the easy separation of the growing peptide chain from the reaction mixture.
Uses
Used in Pharmaceutical Industry:
BOC-HIS(TOS)-MERRIFIELD RESIN is used as a solid support for the synthesis of peptides and proteins for various pharmaceutical applications. It facilitates the stepwise addition of amino acids, enabling the production of specific peptide sequences with high purity and yield.
Used in Research and Development:
In the field of research and development, BOC-HIS(TOS)-MERRIFIELD RESIN is used as a tool for the synthesis of custom peptides and peptide-based compounds. This allows scientists to study the structure, function, and interactions of these molecules in various biological systems.
Used in Organic Synthesis:
BOC-HIS(TOS)-MERRIFIELD RESIN is also used in organic synthesis as an intermediate for the production of various compounds, including pharmaceuticals, agrochemicals, and dyes. Its solid support nature makes it a versatile and efficient tool for the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 33018-91-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,0,1 and 8 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 33018-91:
(7*3)+(6*3)+(5*0)+(4*1)+(3*8)+(2*9)+(1*1)=86
86 % 10 = 6
So 33018-91-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H16O4/c1-2-13-9(12)7-5-3-4-6-8(10)11/h2-7H2,1H3,(H,10,11)
33018-91-6Relevant articles and documents
Novel Myocyte Enhancer Factor 2 (MEF2) modulators
-
Paragraph 0105; 0108-0109, (2019/08/20)
The present disclosure provides novel compounds capable of functioning as Myoctye Enhancer Factor 2 (MEF2) modulators, as well as compositions, pharmaceutical formulations, methods of synthesis and kits. Also provided are methods of treating a condition regulatable by MEF2 and/or MEF2 cofactors using the compounds, compositions, pharmaceutical formulations, and kits provided herein.
NOVEL TRANSCRIPTION FACTOR MODULATORS
-
Paragraph 0178; 0183; 0184, (2014/09/29)
The present disclosure provides novel compounds capable of functioning as transcription factor modulators, as well as compositions, pharmaceutical formulations, and kits. Also provided are methods of treating a condition regulatable by a transcription factor and/or cofactor using the compounds, compositions, pharmaceutical formulations, and kits provided herein.
The synthesis of the vitamers of biotin
Nudelman, Abraham,Nudelman, Ayelet,Marcovici-Mizrahi, Dana,Flint, Dennis
, p. 157 - 168 (2007/10/03)
An efficient synthetic pathway for the preparation of the vitamers of biotin which provides easy access to optically pure KAPA as well as diastereomeric mixtures of DAPA, DTB, and analogs thereof has been developed.
